Navigation Links
Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

and marketable securities as of September 30, 2008 were $65,606,000 compared to $60,589,000 as of March 31, 2008.

"We are in a strong position to execute our product development plan despite the recent turmoil in the financial markets," stated Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "As of September 30th, we had $65 million or $2.10 per share in cash and investments, no debt and we project that on an operating basis we will be cash flow positive in fiscal year 2009 with $28 to $30 million in revenue. We believe our stock is undervalued, and we intend to continue to repurchase our shares under the previously announced 1.25 million share buyback."

For the six-month period ended September 30, 2008, total revenue was $18,750,000. Royalty and other revenue for the six-month period ended September 30, 2008 was $10,073,000. Operating expenses for the six-month period ended September 30, 2008 were $11,117,000, compared to $10,746,000, exclusive of the net gain of $40,170,000 from litigation settlement, for the same period in fiscal year 2007. Net income for the six-month period ended September 30, 2008 was $8,421,000 or $0.27 per diluted share compared to a net gain of $40,546,000 or $1.30 per diluted share in the same period in fiscal year 2008.

Corporate Update

RG1068 for Imaging of the Pancreas

We are currently enrolling patients in a Phase 3 clinical trial of RG1068, synthetic human secretin, designed to assess the ability of RG1068 enhanced magnetic resonance imaging (MRI) to improve the detection of pancreatic duct abnormalities relative to MRI alone. Detailed visual assessment of the pancreatic ducts is important in the assessment, diagnosis and treatment of diseases such as acute and chronic pancreatitis. This study is being conducted at approximately 25 clinical sites within the United States and Canada and will enroll approximately 250 patients. This program has been granted Fast Track De
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
2. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
3. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
4. Repligen Announces Share Repurchase Program
5. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
6. Repligen Elects Earl Henry, M.D. to the Board of Directors
7. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
8. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
9. Stereotaxis Reports Third Quarter 2008 Financial Results
10. Volcano Reports 40 Percent Growth in Quarterly Revenues
11. Dialysis Corporation of America Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Only 20 percent of healthcare ... Affordable Care Act according to a new report . ... responding to a request from Smart Data pioneer ... lead providers to violate privacy laws in many states. , ... many hospitals and clinics are failing to do so in ...
(Date:8/21/2014)... 21, 2014 Inc. magazine ranked Centurion ... 500|5000, an exclusive ranking of the nation's fastest-growing private ... the most important segment of the economy—America’s independent entrepreneurs. ... LinkedIn, Zillow, and many other well-known names gained early ... is proud to have been named to the Inc. ...
(Date:8/21/2014)... Houston, TX (PRWEB) August 21, 2014 Sometimes you ... destiny. , In his new book “From Zero to a Hundred: ... police officer, shares his story of surviving a broken family, a ... “Adversity brings affirmation of who you were created to be,” Roy ... zero,’ which is why I know my purpose today of helping ...
(Date:8/21/2014)... CQIIP, Continuous Quality Immunization Improvement ... Control and Prevention and the Department of Defense. ... the immunization standards and are administered in accordance ... on Immunizations. , ACC chose to adopt the ... place to protect patients, improve efficiency, and increase ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... aging interventions and addressing the challenges of ... concept, OncoFinder, for signalome-wide pathway analysis. ... robust cross-platform analysis of gene expression data ... research, published in the journal Frontiers in ...
Breaking Medicine News(10 mins):Health News:Report: Only 20 Percent of Healthcare Providers Meet ACA Requirement 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2
... JUPITER, FL, May 28, 2009 Current tests to identify specific ... diseases (such as mad cow) in animals and humans, can ... results a time-lag that may put human populations at ... Research Institute,s Florida campus have developed a new method that ...
... Inc. (NYSE: DVA ) announced today ... the Company,s Board of Directors. (Logo: ... former President of American Express International, Japan, Asia-Pacific, ... the Consumer Card business across 12 countries, heading ...
... Annoying seasonal allergies is now a year round threat. ... to nest in the home. Indoor air pollution is ... chemicals, synthetic materials and impurities. To expel these year ... to home ventilation and eliminates allergens.The EZ Breathe system ...
... The best respiratory protection is useless if it ... series, Draeger dedicated special attention to ensuring that the ... comfort of the wearer was maximized. While offering extremely ... been compromised. (Photo: http://www.newscom.com/cgi-bin/prnh/20090528/NE24067 ...
... Darwin National,Assurance Company, a member company of Allied ... ), today announced that Becky Cox has been ... Ms. Cox will,be responsible for the continued development ... Fred Bautista, Vice,President, Business Development, Healthcare. , ...
... of overdose, and potential liver damage, is still too ... -- One month after mandating stricter warning labels about ... U.S. regulators are contemplating even tougher standards. , Advisers ... late next month to review a new agency report ...
Cached Medicine News:Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 2Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 3Health News:Pamela M. Arway Joins DaVita Board of Directors 2Health News:EZ Breathe(R) Home Ventilation System Expels Allergens, Moisture and Smells 2Health News:Comfort Matters - The new Draeger Series of Filtering Facepiece Respirators Demonstrate Exceptional Wearer Comfort 2Health News:Darwin Appoints Becky Cox Vice President, Business Development, Healthcare 2Health News:Darwin Appoints Becky Cox Vice President, Business Development, Healthcare 3Health News:FDA Report Urges Tougher Acetaminophen Warning 2
(Date:8/20/2014)... Aug. 20, 2014 Research and Markets  has ... Pralmorelin" report to their offering. Global ... data on Pralmorelin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:8/20/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), ... that its VENTANA System for Primary Diagnosis 1 ... Union for routine pathology, including primary diagnosis with ... Virtuoso software coupled with either the VENTANA iScan ... provides automated digital slide creation, case management and ...
(Date:8/20/2014)... ANN ARBOR, Mich. and ... a non-profit corporation established to bring cutting-edge next-generation ... trials to cancer patients, today announced a collaboration ... molecular capabilities to characterize patient tissue samples from ... be sensitive or resistant to TESARO,s TSR-011.  This may ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a ... the chronically ill, a leading fulfillment provider of direct ... revolutionary cell phone centric e -health products and ... Dividend will be Ex-Dividend to all shareholders of record ...
... ENDP ) today announced that David Holveck, president ... Morgan 30th Annual Healthcare Conference on Monday, January 9, 2012 ... the Westin St. Francis in San Francisco, Calif. ... be available on the company,s website at http://www.endo.com/ .  ...
Cached Medicine Technology:Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy 2
... Solution is the ... povidone-iodine. It is a ... kills gram-positive and gram-negative ... organisms), as well as ...
... Aplicare's disposable 1-ounce pouches are designed for ... waste. They are used in nursing homes, ... rooms and many other hospital departments. This ... is a mild antiseptic, germicidal and cleansing ...
... Aplicare's Iodine Scrub is a gentle ... formulated to prevent dryness. Povidone Iodine is ... gram-negative and gram-positive bacteria, fungi, viruses, protozoa ... lather; the first step in patient pre-operative ...
... Iodine Scrub is a gentle and effective ... prevent dryness. Povidone Iodine is known to ... gram-positive bacteria, fungi, viruses, protozoa and yeasts. ... first step in patient pre-operative prepping, as ...
Medicine Products: